GASTROLITHIASIS

This adverse event was reported 30 times

GASTROLITHIASIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 NEOSTIGMINE METHYLSULFATE 1 0.0023
1 CARBIDOPA, LEVODOPA AND ENTACAPONE 1 0.0021
2 ADEFOVIR DIPIVOXIL 2 0.0016
3 FLUMAZENIL 1 0.0011
4 FLURBIPROFEN 1 0.0007
5 LEVOCARNITINE 2 0.0005
6 OMEGA-3-ACID ETHYL ESTERS 1 0.0005
7 ESTAZOLAM 1 0.0005
8 ETOMIDATE INJECTION 1 0.0005
9 CISATRACURIUM BESYLATE 1 0.0004
See all drugs enriched for association with GASTROLITHIASIS